when the theoretical risks of using continuous cell lines as substrates to produce biological products are balanced against the available data , it would appear reasonable to proceed with the use of such cell lines for the development of biologics because the benefits of those products appear to exceed by far the potential risks associated with the use of these cell substrates .
C0005522
biological products
C0007634
cell